APA

Sallinen J., Link R. E., Haapalinna A., Viitamaa T., Kulatunga M., Sjöholm B., Macdonald E., Pelto-Huikko M., Leino T., Barsh G. S., Kobilka B. K. & Scheinin M. (19970227). Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. : Molecular pharmacology.

Chicago

Sallinen J, Link R E, Haapalinna A, Viitamaa T, Kulatunga M, Sjöholm B, Macdonald E, Pelto-Huikko M, Leino T, Barsh G S, Kobilka B K and Scheinin M. 19970227. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. : Molecular pharmacology.

Harvard

Sallinen J., Link R. E., Haapalinna A., Viitamaa T., Kulatunga M., Sjöholm B., Macdonald E., Pelto-Huikko M., Leino T., Barsh G. S., Kobilka B. K. and Scheinin M. (19970227). Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. : Molecular pharmacology.

MLA

Sallinen J, Link R E, Haapalinna A, Viitamaa T, Kulatunga M, Sjöholm B, Macdonald E, Pelto-Huikko M, Leino T, Barsh G S, Kobilka B K and Scheinin M. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist. : Molecular pharmacology. 19970227.